サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1678545

皮下避妊インプラントの市場規模、シェア、動向分析レポート：製品別、流通チャネル別、地域別、セグメント予測、2025年～2030年

Subdermal Contraceptive Implants Market Size, Share & Trends Analysis Report By Product (Etonogestrel Implant, Levonorgestrel Implant), By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030

出版日
ページ情報
英文 80 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
皮下避妊インプラントの市場規模、シェア、動向分析レポート：製品別、流通チャネル別、地域別、セグメント予測、2025年～2030年
出版日: 2025年02月04日
発行: Grand View Research
ページ情報: 英文 80 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

皮下避妊インプラント市場の成長と動向

Grand View Research, Inc.の最新レポートによると、世界の皮下避妊インプラント市場規模は2030年までに17億4,000万米ドルに達すると推定され、2025～2030年にかけてCAGR 7.61%で成長する見込みです。

市場における複数の最新避妊薬の導入、様々な避妊方法に関する意識の高まり、一人当たりの所得の高さは、避妊用皮下インプラント市場を牽引する主要要因の一部です。

Guttmacher Instituteによると、2014年には約2,000万人の女性が公的資金による避妊サービスを必要としていました。CDCによると、2017年、米国では約4,690万人の女性が少なくとも1つの避妊法を使用していました。皮下インプラントは女性にとって長期的な避妊の選択肢です。避妊のための皮下インプラントは、ポリマーカプセルまたはロッドの形で皮下に挿入されます。黄体ホルモンはゆっくりと安定した速度で放出され、1～5年間有効な避妊効果が得られます。

公的資金による家族計画サービスは、女性が妊娠を避けたり、計画的に妊娠したりするのを助ける。2012年、サウスカロライナ州保健福祉省（SCDHHS）は、産後すぐの長時間作用型可逆的避妊薬（LARC）挿入に関するメディケイドの決済方針を改定しました。この新しい決済方針の下で、医療提供者は、診断関連グループ（DRG）に加えて、家族計画修飾子付きのJコードを使用することで、挿入手順とIUDまたはインプラントの費用を請求することができます。

インプラントは、サハラ以南のアフリカの女性に最も広く使用されている避妊法です。これは、メーカー、ドナー、政府、国際機関の間の官民パートナーシップのおかげであり、商品コストを下げ、製品の入手可能性を高めるのに役立っています。南アフリカ、マラウイ、ルワンダでは、避妊具の使用量が増加しています。PLOS.orgによると、マラウイでは2016年、長時間作用型可逆的避妊法（LARC）の使用率が都市部で10.21％、農村部で9.66％に達しました。2012年には、2020年までに1億2,000万人の女性が近代的な避妊法を利用できるようにするため、「家族計画2020（FP2020）」と呼ばれる取り組みが開始されました。

皮下避妊インプラント市場レポートハイライト

  • エトノゲストレルインプラントが市場を独占し、2024年には64.73%のシェアを占めます。促進要因は、意図しない妊娠と安全でない中絶の増加。
  • 病院が市場を独占し、2024年には54.37%のシェアを占めます。病院は患者に包括的な環境を提供し、検査、診察、処置など幅広いサービスを提供しており、これがセグメント成長の原動力となっています。
  • 北米の皮下避妊インプラント市場は2024年に64.91％のシェアを占め、市場を独占しました。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 皮下避妊インプラント市場の変数、動向、範囲

  • 市場系統の展望
    • 親市場の展望
    • 関連/補助市場展望
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
    • 産業の課題と機会の分析
  • 皮下避妊インプラント市場分析ツール
    • ポーターの分析
    • PESTEL分析

第4章 皮下避妊インプラント市場：製品別、推定・動向分析

  • 定義と範囲
  • 製品市場シェア分析、2024年と2030年
  • セグメントダッシュボード
  • 皮下避妊インプラント市場：製品別、2018～2030年
    • エトノゲストレルインプラント
    • レボノルゲストレルインプラント

第5章 皮下避妊インプラント市場：流通チャネル別、推定・動向分析

  • 定義と範囲
  • 流通チャネル市場シェア分析、2024年と2030年
  • セグメントダッシュボード
  • 皮下避妊インプラント市場：流通チャネル別、2018～2030年
    • 病院
    • 婦人科クリニック
    • コミュニティ医療センター
    • その他

第6章 皮下避妊インプラント市場：地域別、推定・動向分析

  • 定義と範囲
  • 地域別市場シェア分析、2024年と2030年
  • 皮下避妊インプラント市場シェア、地域別、2024年と2030年
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • デンマーク
    • スウェーデン
    • ノルウェー
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • タイ
  • ラテンアメリカ
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第7章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 企業分類
  • 企業の市場シェア分析
  • 企業ヒートマップ分析
  • 戦略マッピング
  • 企業プロファイル
    • Merck & Co., Inc.
    • Shanghai Dahua Pharmaceutical Co., Ltd.
    • Bayer AG
    • Baxter
    • BD
    • Gerresheimer AG
    • Pfizer, Inc.
    • Novartis AG
    • SCHOTT
    • Lilly
図表

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 North America subdermal contraceptive implants market estimates and forecasts by product, 2018 - 2030 (USD Million)
  • Table 4 North America subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 5 U.S. subdermal contraceptive implants market estimates and forecasts by product, 2018 - 2030 (USD Million)
  • Table 6 U.S. subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 7 Canada subdermal contraceptive implants market estimates and forecasts by product, 2018 - 2030 (USD Million)
  • Table 8 Canada subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 9 Mexico subdermal contraceptive implants market estimates and forecasts by product, 2018 - 2030 (USD Million)
  • Table 10 Mexico subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 11 Europe subdermal contraceptive implants market estimates and forecasts by product, 2018 - 2030 (USD Million)
  • Table 12 Europe subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 13 UK subdermal contraceptive implants market estimates and forecasts by product, 2018 - 2030 (USD Million)
  • Table 14 UK subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 15 Germany subdermal contraceptive implants market estimates and forecasts by product, 2018 - 2030 (USD Million)
  • Table 16 Germany subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 17 France subdermal contraceptive implants market estimates and forecasts by product, 2018 - 2030 (USD Million)
  • Table 18 France subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 19 Italy subdermal contraceptive implants market estimates and forecasts by product, 2018 - 2030 (USD Million)
  • Table 20 Italy subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 21 Spain subdermal contraceptive implants market estimates and forecasts by product, 2018 - 2030 (USD Million)
  • Table 22 Spain subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 23 Denmark subdermal contraceptive implants market estimates and forecasts by product, 2018 - 2030 (USD Million)
  • Table 24 Denmark subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 25 Sweden subdermal contraceptive implants market estimates and forecasts by product, 2018 - 2030 (USD Million)
  • Table 26 Sweden subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 27 Norway subdermal contraceptive implants market estimates and forecasts by product, 2018 - 2030 (USD Million)
  • Table 28 Norway subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 29 Asia Pacific subdermal contraceptive implants market estimates and forecasts by product, 2018 - 2030 (USD Million)
  • Table 30 Asia Pacific subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 31 Japan subdermal contraceptive implants market estimates and forecasts by product, 2018 - 2030 (USD Million)
  • Table 32 Japan subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 33 China subdermal contraceptive implants market estimates and forecasts by product, 2018 - 2030 (USD Million)
  • Table 34 China subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 35 India subdermal contraceptive implants market estimates and forecasts by product, 2018 - 2030 (USD Million)
  • Table 36 India subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 37 Australia subdermal contraceptive implants market estimates and forecasts by product, 2018 - 2030 (USD Million)
  • Table 38 Australia subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 39 South Korea subdermal contraceptive implants market estimates and forecasts by product, 2018 - 2030 (USD Million)
  • Table 40 South Korea subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 41 Thailand subdermal contraceptive implants market estimates and forecasts by product, 2018 - 2030 (USD Million)
  • Table 42 Thailand subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 43 Latin America subdermal contraceptive implants market estimates and forecasts by product, 2018 - 2030 (USD Million)
  • Table 44 Latin America subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 45 Brazil subdermal contraceptive implants market estimates and forecasts by product, 2018 - 2030 (USD Million)
  • Table 46 Brazil subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 47 Argentina subdermal contraceptive implants market estimates and forecasts by product, 2018 - 2030 (USD Million)
  • Table 48 Argentina subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 49 MEA subdermal contraceptive implants market estimates and forecasts by product, 2018 - 2030 (USD Million)
  • Table 50 MEA subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 51 South Africa subdermal contraceptive implants market estimates and forecasts by product, 2018 - 2030 (USD Million)
  • Table 52 South Africa subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 53 Saudi Arabia subdermal contraceptive implants market estimates and forecasts by product, 2018 - 2030 (USD Million)
  • Table 54 Saudi Arabia subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 55 UAE subdermal contraceptive implants market estimates and forecasts by product, 2018 - 2030 (USD Million)
  • Table 56 UAE subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 57 Kuwait subdermal contraceptive implants market estimates and forecasts by product, 2018 - 2030 (USD Million)
  • Table 58 Kuwait subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Subdermal contraceptive implants market segmentation
  • Fig. 2 Information procurement
  • Fig. 3 Data analysis models
  • Fig. 4 Market formulation and validation
  • Fig. 5 Data validating & publishing
  • Fig. 6 Market snapshot
  • Fig. 7 Segment snapshot (1/2)
  • Fig. 8 Segment snapshot (2/2)
  • Fig. 9 Competitive landscape snapshot
  • Fig. 10 Subdermal contraceptive implants- market size and growth prospects (USD Million)
  • Fig. 11 Subdermal contraceptive implants market: industry value chain analysis
  • Fig. 12 Subdermal contraceptive implants market: market dynamics
  • Fig. 13 Subdermal contraceptive implants market: porter's analysis
  • Fig. 14 Subdermal contraceptive implants market: pestel analysis
  • Fig. 15 Subdermal contraceptive implants market share by product 2024 & 2030 (USD Million)
  • Fig. 16 Subdermal contraceptive implants market, by product: key takeaways
  • Fig. 17 Subdermal contraceptive implants market, by product: market share, 2024 & 2030
  • Fig. 18 Etonogestrel implant market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 19 Levonorgestrel implant market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Subdermal contraceptive implants market share by distribution channel 2024 & 2030 (USD Million)
  • Fig. 21 Subdermal contraceptive implants market, by distribution channel: key takeaways
  • Fig. 22 Subdermal contraceptive implants market, by distribution channel: market share, 2024 & 2030
  • Fig. 23 Hospital market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Gynecology clinics market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Community health care centres market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Others market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Subdermal contraceptive implants market revenue, by region, 2024 & 2030 (USD Million)
  • Fig. 28 Regional marketplace: key takeaways
  • Fig. 29 Regional marketplace: key takeaways
  • Fig. 30 North america subdermal contraceptive implants market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 U.s. Subdermal contraceptive implants market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Canada subdermal contraceptive implants market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Mexico subdermal contraceptive implants market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Europe subdermal contraceptive implants market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Uk subdermal contraceptive implants market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Germany subdermal contraceptive implants market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 France subdermal contraceptive implants market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Italy subdermal contraceptive implants market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Spain subdermal contraceptive implants market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Denmark subdermal contraceptive implants market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Sweden subdermal contraceptive implants market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Norway subdermal contraceptive implants market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Asia pacific subdermal contraceptive implants market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 Japan subdermal contraceptive implants market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 China subdermal contraceptive implants market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 India subdermal contraceptive implants market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Australia subdermal contraceptive implants market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 South korea subdermal contraceptive implants market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Thailand subdermal contraceptive implants market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Latin america subdermal contraceptive implants market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Brazil subdermal contraceptive implants market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Argentina subdermal contraceptive implants market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Mea subdermal contraceptive implants market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Saudi arabia subdermal contraceptive implants market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 South africa subdermal contraceptive implants market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Uae subdermal contraceptive implants market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Kuwait subdermal contraceptive implants market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Key company categorization
  • Fig. 59 Company market positioning
  • Fig. 60 Key company market share analysis, 2024
  • Fig. 61 Strategic framework
目次
Product Code: GVR-3-68038-848-0

Subdermal Contraceptive Implants Market Growth & Trends:

The global subdermal contraceptive implants market size is estimated to reach USD 1.74 billion by 2030, registering to grow at a CAGR of 7.61% from 2025 to 2030 according to a new report by Grand View Research, Inc. Introduction of several modern contraceptives in the market, growing awareness about various birth control methods, and high per capita income are some of the key factors driving the market for subdermal implants for birth control.

According to the Guttmacher Institute, in 2014, approximately 20 million women needed publicly funded contraceptive services. According to CDC, in 2017, nearly 46.9 million women in the U.S. were using at least one method of contraception. Subdermal implant is a long-term birth control option for women. Subdermal implants for contraception are in the form of polymer capsules or rods placed under the skin. The progestational hormone is released at a slow and stable rate, providing effective contraception for 1-5 years.

Publicly funded family planning services help women avoid or plan pregnancies. In 2012, the South Carolina Department of Health and Human Services (SCDHHS) revised the cost associated with Medicaid payment policy for immediate postpartum insertion of Long-Acting Reversible Contraception (LARC). Under this new reimbursement policy, providers are allowed to bill for the insertion procedure and the cost of an IUD or an implant, in addition to the Diagnosis Related Group (DRG) by using J-codes with a family planning modifier.

Implants are the most widely used contraceptive methods by women in sub-Saharan Africa owing to public-private partnerships between manufacturers, donors, governments, and international agencies, which helps lower commodity cost and increase product availability. Contraceptive usage has increased in South Africa, Malawi, and Rwanda. According to PLOS.org, in Malawi, the use of the Long-acting Reversible Contraception (LARC) method reached 10.21% in urban areas in 2016 and 9.66% in rural areas. In 2012, an initiative called Family Planning 2020 (FP2020) was launched to give 120 million women access to modern contraceptive methods by 2020.

Subdermal Contraceptive Implants Market Report Highlights:

  • Etonogestrel implants dominated the market and accounted for a share of 64.73% in 2024. The driving factors are rising unintended pregnancies and unsafe abortions.
  • Hospital dominated the market and accounted for a share of 54.37% in 2024. Hospitals provide a comprehensive environment for patients, offering a wide range of services including tests, consultations, and procedures, which drive segment growth.
  • North America subdermal contraceptive implants market dominated the market with a market share of 64.91% in 2024.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Secondary Sources
    • 1.4.2. List of Primary Sources
    • 1.4.3. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product Outlook
    • 2.2.2. Distribution Channel Outlook
    • 2.2.3. Regional Outlook
  • 2.3. Competitive Insights

Chapter 3. Subdermal Contraceptive Implants Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Drivers Analysis
      • 3.2.1.1. Awareness of family planning
      • 3.2.1.2. Demand for Long-Acting Reversible Contraceptives (LARCs)
      • 3.2.1.3. Technological advancements and product improvements
    • 3.2.2. Market Restraints Analysis
      • 3.2.2.1. Side effects and health concerns
    • 3.2.3. Industry Challenges and Opportunity Analysis
  • 3.3. Subdermal Contraceptive Implants Market Analysis Tools
    • 3.3.1. Porter's Analysis
      • 3.3.1.1. Bargaining power of the suppliers
      • 3.3.1.2. Bargaining power of the buyers
      • 3.3.1.3. Threats of substitution
      • 3.3.1.4. Threats from new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic and Social landscape
      • 3.3.2.3. Technological landscape
      • 3.3.2.4. Environmental landscape
      • 3.3.2.5. Legal landscape

Chapter 4. Subdermal Contraceptive Implants Market: Product Estimates & Trend Analysis

  • 4.1. Definition and Scope
  • 4.2. Product Market Share Analysis, 2024 & 2030
  • 4.3. Segment Dashboard
  • 4.4. Subdermal Contraceptive Implants Market: By Product, 2018 to 2030
    • 4.4.1. Etonogestrel Implant
      • 4.4.1.1. Etonogestrel implant market revenue estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.4.2. Levonorgestrel Implant
      • 4.4.2.1. Levonorgestrel implant market revenue estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 5. Subdermal Contraceptive Implants Market: Distribution Channel Estimates & Trend Analysis

  • 5.1. Definition and Scope
  • 5.2. Distribution Channel Market Share Analysis, 2024 & 2030
  • 5.3. Segment Dashboard
  • 5.4. Subdermal Contraceptive Implants Market: By Distribution Channel, 2018 to 2030
    • 5.4.1. Hospital
      • 5.4.1.1. Hospital market revenue estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.4.2. Gynecology Clinics
      • 5.4.2.1. Gynecology clinics market revenue estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.4.3. Community Health Care Centers
      • 5.4.3.1. Community health care centers market revenue estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.4.4. Others
      • 5.4.4.1. Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 6. Subdermal Contraceptive Implants Market: Regional Estimates & Trend Analysis by Region, Product

  • 6.1. Definition and Scope
  • 6.2. Regional Market Share Analysis, 2024 & 2030
  • 6.3. Subdermal Contraceptive Implants Market Share, By Region, 2024 & 2030 (USD Million)
  • 6.4. North America
    • 6.4.1. North America Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.2. U.S.
      • 6.4.2.1. U.S. Key Country Dynamics
      • 6.4.2.2. Regulatory Landscape/Reimbursement Scenario
      • 6.4.2.3. Competitive Insights
      • 6.4.2.4. U.S. Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. Canada
      • 6.4.3.1. Canada Key Country Dynamics
      • 6.4.3.2. Regulatory Landscape/Reimbursement Scenario
      • 6.4.3.3. Competitive Insights
      • 6.4.3.4. Canada Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. Mexico
      • 6.4.4.1. Mexico Key Country Dynamics
      • 6.4.4.2. Regulatory Landscape/Reimbursement Scenario
      • 6.4.4.3. Competitive Insights
      • 6.4.4.4. Mexico Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Europe
    • 6.5.1. Europe Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. UK
      • 6.5.2.1. UK Key Country Dynamics
      • 6.5.2.2. Regulatory Landscape/Reimbursement Scenario
      • 6.5.2.3. Competitive Insights
      • 6.5.2.4. U.K. Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. Germany
      • 6.5.3.1. Germany Key Country Dynamics
      • 6.5.3.2. Regulatory Landscape/Reimbursement Scenario
      • 6.5.3.3. Competitive Insights
      • 6.5.3.4. Germany Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.4. France
      • 6.5.4.1. France Key Country Dynamics
      • 6.5.4.2. Regulatory Landscape/Reimbursement Scenario
      • 6.5.4.3. Competitive Insights
      • 6.5.4.4. France Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.5. Italy
      • 6.5.5.1. Italy Key Country Dynamics
      • 6.5.5.2. Regulatory Landscape/Reimbursement Scenario
      • 6.5.5.3. Competitive Insights
      • 6.5.5.4. Italy Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.6. Spain
      • 6.5.6.1. Spain Key Country Dynamics
      • 6.5.6.2. Regulatory Landscape/Reimbursement Scenario
      • 6.5.6.3. Competitive Insights
      • 6.5.6.4. Spain Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.7. Denmark
      • 6.5.7.1. Denmark Spain Key Country Dynamics
      • 6.5.7.2. Regulatory Landscape/Reimbursement Scenario
      • 6.5.7.3. Competitive Insights
      • 6.5.7.4. Denmark Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.8. Sweden
      • 6.5.8.1. Sweden Key Country Dynamics
      • 6.5.8.2. Regulatory Landscape/Reimbursement Scenario
      • 6.5.8.3. Competitive Insights
      • 6.5.8.4. Sweden Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.9. Norway
      • 6.5.9.1. Norway Key Country Dynamics
      • 6.5.9.2. Regulatory Landscape/Reimbursement Scenario
      • 6.5.9.3. Competitive Insights
      • 6.5.9.4. Norway Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Asia Pacific
    • 6.6.1. Asia Pacific Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.2. China
      • 6.6.2.1. China Key Country Dynamics
      • 6.6.2.2. Regulatory Landscape/Reimbursement Scenario
      • 6.6.2.3. Competitive Insights
      • 6.6.2.4. China Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. Japan
      • 6.6.3.1. Japan Key Country Dynamics
      • 6.6.3.2. Regulatory Landscape/Reimbursement Scenario
      • 6.6.3.3. Competitive Insights
      • 6.6.3.4. Japan Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.4. India
      • 6.6.4.1. India Key Country Dynamics
      • 6.6.4.2. Regulatory Landscape/Reimbursement Scenario
      • 6.6.4.3. Competitive Insights
      • 6.6.4.4. India Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.5. South Korea
      • 6.6.5.1. South Korea Key Country Dynamics
      • 6.6.5.2. Regulatory Landscape/Reimbursement Scenario
      • 6.6.5.3. Competitive Insights
      • 6.6.5.4. South Korea Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.6. Australia
      • 6.6.6.1. Australia Key Country Dynamics
      • 6.6.6.2. Regulatory Landscape/Reimbursement Scenario
      • 6.6.6.3. Competitive Insights
      • 6.6.6.4. Australia Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.7. Thailand
      • 6.6.7.1. Thailand Key Country Dynamics
      • 6.6.7.2. Regulatory Landscape/Reimbursement Scenario
      • 6.6.7.3. Competitive Insights
      • 6.6.7.4. Thailand Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Latin America
    • 6.7.1. Latin America Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.7.2. Brazil
      • 6.7.2.1. Brazil Key Country Dynamics
      • 6.7.2.2. Regulatory Landscape/Reimbursement Scenario
      • 6.7.2.3. Competitive Insights
      • 6.7.2.4. Brazil Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.7.3. Argentina
      • 6.7.3.1. Argentina Key Country Dynamics
      • 6.7.3.2. Regulatory Landscape/Reimbursement Scenario
      • 6.7.3.3. Competitive Insights
      • 6.7.3.4. Argentina Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8. Middle East and Africa (MEA)
    • 6.8.1. Middle East and Africa Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.8.2. South Africa
      • 6.8.2.1. South Africa Key Country Dynamics
      • 6.8.2.2. Regulatory Landscape/Reimbursement Scenario
      • 6.8.2.3. Competitive Insights
      • 6.8.2.4. South Africa Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.8.3. Saudi Arabia
      • 6.8.3.1. Saudi Arabia Key Country Dynamics
      • 6.8.3.2. Regulatory Landscape/Reimbursement Scenario
      • 6.8.3.3. Competitive Insights
      • 6.8.3.4. Saudi Arabia Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.8.4. UAE
      • 6.8.4.1. UAE Key Country Dynamics
      • 6.8.4.2. Regulatory Landscape/Reimbursement Scenario
      • 6.8.4.3. Competitive Insights
      • 6.8.4.4. UAE Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.8.5. Kuwait
      • 6.8.5.1. Kuwait Key Country Dynamics
      • 6.8.5.2. Regulatory Landscape/Reimbursement Scenario
      • 6.8.5.3. Competitive Insights
      • 6.8.5.4. Kuwait Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis by Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Market Share Analysis
  • 7.4. Company Heat Map Analysis
  • 7.5. Strategy Mapping
  • 7.6. Company Profiles
    • 7.6.1. Merck & Co., Inc.
      • 7.6.1.1. Participant's Overview
      • 7.6.1.2. Financial Performance
      • 7.6.1.3. Product Benchmarking
      • 7.6.1.4. Recent Developments
    • 7.6.2. Shanghai Dahua Pharmaceutical Co., Ltd.
      • 7.6.2.1. Participant's Overview
      • 7.6.2.2. Financial Performance
      • 7.6.2.3. Product Benchmarking
      • 7.6.2.4. Recent Developments
    • 7.6.3. Bayer AG
      • 7.6.3.1. Participant's Overview
      • 7.6.3.2. Financial Performance
      • 7.6.3.3. Product Benchmarking
      • 7.6.3.4. Recent Developments
    • 7.6.4. Baxter
      • 7.6.4.1. Participant's Overview
      • 7.6.4.2. Financial Performance
      • 7.6.4.3. Product Benchmarking
      • 7.6.4.4. Recent Developments
    • 7.6.5. BD
      • 7.6.5.1. Participant's Overview
      • 7.6.5.2. Financial Performance
      • 7.6.5.3. Product Benchmarking
      • 7.6.5.4. Recent Developments
    • 7.6.6. Gerresheimer AG
      • 7.6.6.1. Participant's Overview
      • 7.6.6.2. Financial Performance
      • 7.6.6.3. Product Benchmarking
      • 7.6.6.4. Recent Developments
    • 7.6.7. Pfizer, Inc.
      • 7.6.7.1. Participant's Overview
      • 7.6.7.2. Financial Performance
      • 7.6.7.3. Product Benchmarking
      • 7.6.7.4. Recent Developments
    • 7.6.8. Novartis AG
      • 7.6.8.1. Participant's Overview
      • 7.6.8.2. Financial Performance
      • 7.6.8.3. Product Benchmarking
      • 7.6.8.4. Recent Developments
    • 7.6.9. SCHOTT
      • 7.6.9.1. Participant's Overview
      • 7.6.9.2. Financial Performance
      • 7.6.9.3. Product Benchmarking
      • 7.6.9.4. Recent Developments
    • 7.6.10. Lilly
      • 7.6.10.1. Participant's Overview
      • 7.6.10.2. Financial Performance
      • 7.6.10.3. Product Benchmarking
      • 7.6.10.4. Recent Developments